TIDMGSK

RNS Number : 3186L

GlaxoSmithKline PLC

18 April 2018

Issued: 18 April 2018, London UK - LSE Announcement

Landmark IMPACT study to be published in NEJM

GlaxoSmithKline plc (LSE/NYSE: GSK) will today announce at 22:00 BST its IMPACT data.

GSK - a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com.

 
 GSK enquiries: 
 UK Media enquiries:   Simon Steel        +44 (0) 20 8047    (London) 
                                           5502 
                       David Daley        +44 (0) 20 8047    (London) 
                                           5502 
 
 Analyst/Investor      Sarah Elton-Farr   +44 (0) 20 8047    (London) 
  enquiries:                               5194 
                       Tom Curry          + 1 215 751 5419   (Philadelphia) 
                       James Dodwell      +44 (0) 20 8047    (London) 
                                           2406 
                       Jeff McLaughlin    +1 215 751 7002    (Philadelphia) 
 
 
 
 Cautionary statement regarding forward-looking statements 
  GSK cautions investors that any forward-looking statements or 
  projections made by GSK, including those made in this announcement, 
  are subject to risks and uncertainties that may cause actual 
  results to differ materially from those projected. Such factors 
  include, but are not limited to, those described under Item 
  3.D Principal risks and uncertainties in the company's Annual 
  Report on Form 20-F for 2017. 
 
  Registered in England & Wales: 
  No. 3888792 
 
  Registered Office: 
  980 Great West Road 
  Brentford, Middlesex 
  TW8 9GS 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCKVLBFVZFXBBF

(END) Dow Jones Newswires

April 18, 2018 05:34 ET (09:34 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.